ArticleMicrobiology insights2015
Biofilm Cohesive Strength as a Basis for Biofilm Recalcitrance: Are Bacterial Biofilms Overdesigned?
Article in Microbiology insights, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Virulence factors and quorum sensing as targets of new therapeutic options by plant-derived compounds against bacterial infections caused by human and animal pathogens.Veterinary world · 2023Review
- Biofilms and their impact on the food industry.Saudi journal of biological sciences · 2023Review
- Distinct Microbiotas Are Associated with Different Production Lines in the Cutting Room of a Swine Slaughterhouse.Microorganisms · 2023Article
- Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance.Microorganisms · 2022Review
- Regulatory network controls microbial biofilm development, withBioengineered · 2022Review
- Long-term antibacterial properties of a nanostructured titanium alloy surface: AnMaterials today. Bio · 2022Article
- Review
- Assessing the Biofilm Formation Capacity of the Wine Spoilage YeastMicroorganisms · 2021Article
- Non-invasive Biofouling Monitoring to Assess Drinking Water Distribution System Performance.Frontiers in microbiology · 2021Article
- Scrub sink contamination and transmission to operating room personnel.New microbes and new infections · 2020Article
- A Textile Pile Debridement Material Consisting of Polyester Fibers for in Vitro Removal of Biofilm.Polymers · 2020Article
- Use of Genetically Modified Bacteria to Repair Cracks in Concrete.Materials (Basel, Switzerland) · 2019Article
- Surfactants as Antimicrobials: A Brief Overview of Microbial Interfacial Chemistry and Surfactant Antimicrobial Activity.Journal of surfactants and detergents · 2019Review
- Towards standardized mechanical characterization of microbial biofilms: analysis and critical review.NPJ biofilms and microbiomes · 2018Review
- Introductory Editorial: Water Microbiology.Microbiology insights · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial biofilms are highly resistant to common antibacterial treatments, and several physiological explanations have been offered to explain the recalcitrant nature of bacterial biofilms. Herein, a biophysical aspect of biofilm recalcitrance is being reported on. While engineering structures are often overdesigned with a factor of safety (FOS) usually under 10, experimental measurements of biofilm cohesive strength suggest that the FOS is on the order of thousands. In other words, bacterial biofilms appear to be designed to withstand extreme forces rather than typical or average loads. In scenarios requiring the removal or control of unwanted biofilms, this emphasizes the importance of considering strategies for structurally weakening the biofilms in conjunction with bacterial inactivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.